Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11981699 Phosphoramidates for the treatment of hepatitis B virus

Patent 11981699 was granted and assigned to Emory University on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Emory University

Current Assignee

Emory University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119816990

Patent Inventor Names

Abel de la Rosa0

Gregory R. Bluemling0

Date of Patent

May 14, 2024

Patent Application Number

173915860

Date Filed

August 2, 2021

Patent Citations

‌

US Patent 7888330 Phosphoramidate derivatives of FAU

‌

US Patent 7608597 Methods and compositions for treating hepatitis C virus

‌

US Patent 10683319 Phosphoramidates for the treatment of hepatitis B virus

Patent Primary Examiner

‌

Brian J Davis

Patent abstract

Disclosed are compounds to the treatment of infectious diseases and methods of treating such diseases. The compounds are derivatives of clevudine.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11981699 Phosphoramidates for the treatment of hepatitis B virus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API